Why the study?
Does treatment with carbimazole and propranolol improve cardiac function in a patient with hyperthyroidism-induced dilated cardiomyopathy?
Does treatment with carbimazole and propranolol improve cardiac function in a patient with hyperthyroidism-induced dilated cardiomyopathy?
Hyperthyroidism-induced dilated cardiomyopathy is a potentially reversible condition that can recover with prompt antithyroid and beta-blocker therapy.
Supports potential reversibility of hyperthyroidism-induced cardiomyopathy; leaves open confirmation in prospective trials.
Dilated cardiomyopathy (DCM) is a rare but potentially reversible complication of hyperthyroidism, often resulting from severe thyrotoxicosis, leading to ventricular dilatation and reduced systolic function. A 45-year-old patient presented with progressive dyspnea and peripheral edema. Laboratory tests and imaging confirmed hyperthyroidism-induced DCM with a reduced ejection fraction (30%). Treatment with carbimazole and propranolol resulted in the normalization of thyroid function and cardiac recovery within three months. Hyperthyroidism can induce cardiac remodeling through genomic and non-genomic mechanisms of thyroid hormones, leading to reversible DCM. Early diagnosis and management are essential to avoid long-term complications, as delayed treatment may result in irreversible myocardial damage. This case highlights the need for multidisciplinary collaboration.
No takes yet. Share an insight, caveat, or question.
Elgharnati et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: